GENEVA, April 18 -- LEIBNIZ-INSTITUT FUR IMMUNTHERAPIE (LIT) (Franz-Josef-StrauB-Allee 1193053 Regensburg) filed a patent application (PCT/EP2025/078956) for "ENGINEERED TNFR LIGANDS" on Oct 08, 2025. With publication no. WO/2026/078056, the details related to the patent application was published on Apr 16, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HEHLGANS, Thomas (Erlenweg 193173 Wenzenbach), BITTNER, Sebastian (Edmund-Baer-Ring 3A91154 Roth), FEUERER, Markus (Schutzenheimweg 15b93049 Regensburg)
Abstract: The present invention provides a new therapeutic approach for the treatment o...